APA (7th ed.) Citation

Feltl, D., Závadová, E., Pála, M., & Hozák, P. Posttreatment plasma transforming growth factor beta 1 ( TGF-beta 1) level predicts for late morbidity in patients with advanced head and neck cancer.

Chicago Style (17th ed.) Citation

Feltl, D., E. Závadová, M. Pála, and Pavel Hozák. Posttreatment Plasma Transforming Growth Factor Beta 1 ( TGF-beta 1) Level Predicts for Late Morbidity in Patients with Advanced Head and Neck Cancer.

MLA (9th ed.) Citation

Feltl, D., et al. Posttreatment Plasma Transforming Growth Factor Beta 1 ( TGF-beta 1) Level Predicts for Late Morbidity in Patients with Advanced Head and Neck Cancer.